(Q37428522)

20 August 2017

1 reference

title

Clinical, pathological, and immunologic aspects of the multiple sclerosis model in common marmosets (Callithrix jacchus). (English)

1 reference

20 August 2017

0 references

0 references

Bert A 't Hart

1

1 reference

PubMed ID

19337065

20 August 2017

Luca Massacesi

series ordinal

2

1 reference

20 August 2017

1 April 2009

1 reference

Journal of Neuropathology & Experimental Neurology

20 August 2017

1 reference

20 August 2017

68

1 reference

20 August 2017

4

1 reference

20 August 2017

341-355

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

20 August 2017

1 reference

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Experimental autoimmune encephalomyelitis as a model of immune-mediated CNS disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

The use of animal models to investigate the pathogenesis of neuroinflammatory disorders of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Therapeutic approaches in multiple sclerosis: lessons from failed and interrupted treatment trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Utility of animal models for identification of potential therapeutics for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Antigen-specific tolerogenic and immunomodulatory strategies for the treatment of autoimmune arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Tolerance: of mice and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Of mice and not men: differences between mouse and human immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Evaluating the validity of animal models for research into therapies for immune-based disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

OBSERVATIONS ON ATTEMPTS TO PRODUCE ACUTE DISSEMINATED ENCEPHALOMYELITIS IN MONKEYS

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Studies on acute disseminated encephalomyelitis produced experimentally in rhesus monkeys; disseminated encephalomyelitis produced in monkeys with their own brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Remitting-relapsing EAE in nonhuman primates: a valid model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Experimental allergic encephalomyelitis in cynomolgus monkeys. Quantitation of T cell responses in peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Non-human primate models of experimental autoimmune encephalomyelitis: Variations on a theme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: a new model for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Histopathological characterization of magnetic resonance imaging-detectable brain white matter lesions in a primate model of multiple sclerosis: a correlative study in the experimental autoimmune encephalomyelitis model in common marmosets (Callithr

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Modelling of multiple sclerosis: lessons learned in a non-human primate

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Magnetic resonance imaging as a surrogate outcome measure of disability in multiple sclerosis: have we been overly harsh in our assessment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Antibody-enhanced cross-presentation of self antigen breaks T cell tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Quantitative MRI-pathology correlations of brain white matter lesions developing in a non-human primate model of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Demyelinated neocortical lesions in marmoset autoimmune encephalomyelitis mimic those in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Diffuse cortical atrophy in a marmoset model of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Monocyte/macrophage differentiation in early multiple sclerosis lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Expression of accessory molecules and cytokines in acute EAE in marmoset monkeys (Callithrix jacchus).

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Decay-accelerating factor (CD55) is expressed by neurons in response to chronic but not acute autoimmune central nervous system inflammation associated with complement activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Frontline: Epitope recognition on the myelin/oligodendrocyte glycoprotein differentially influences disease phenotype and antibody effector functions in autoimmune demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Demyelination and axonal damage in a non-human primate model of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Pathogenesis of axonal and neuronal damage in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

The human CMV-UL86 peptide 981-1003 shares a crossreactive T-cell epitope with the encephalitogenic MOG peptide 34-56, but lacks the capacity to induce EAE in rhesus monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Imaging of white matter lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

MRI-guided immunotherapy development for multiple sclerosis in a primate

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Prevention of experimental autoimmune encephalomyelitis in common marmosets using an anti-IL-12p40 monoclonal antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Proinflammatory Bacterial Peptidoglycan as a Cofactor for the Development of Central Nervous System Autoimmune Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Phagocytes containing a disease-promoting Toll-like receptor/Nod ligand are present in the brain during demyelinating disease in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Epitope specificity of demyelinating monoclonal autoantibodies directed against the human myelin oligodendrocyte glycoprotein (MOG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Molecular characterization of antibody specificities against myelin/oligodendrocyte glycoprotein in autoimmune demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Immune responses against the myelin/oligodendrocyte glycoprotein in experimental autoimmune demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Marmoset fine B cell and T cell epitope specificities mapped onto a homology model of the extracellular domain of human myelin oligodendrocyte glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Antigen presentation in the CNS by myeloid dendritic cells drives progression of relapsing experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

T cell repertoire diversity is required for relapses in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Myelin/oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis in common marmosets: the encephalitogenic T cell epitope pMOG24-36 is presented by a monomorphic MHC class II molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Frequency, heterogeneity and encephalitogenicity of T cells specific for myelin oligodendrocyte glycoprotein in naive outbred primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Nonhuman primate infections after organ transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

A fingerprint left by cytomegalovirus infection in the human T cell compartment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

The multiple sclerosis- and narcolepsy-associated HLA class II haplotype includes the DRB5*0101 allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

The inheritance of resistance alleles in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Identification of an Mhc-DPB1 allele involved in susceptibility to experimental autoimmune encephalomyelitis in rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

The major histocompatibility complex influences the ethiopathogenesis of MS-like disease in primates at multiple levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Major histocompatibility complex class II polymorphisms in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Nomenclature for the major histocompatibility complexes of different species: a proposal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

The common marmoset: a new world primate species with limited Mhc class II variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Reactivation by exon shuffling of a conserved HLA-DR3-like pseudogene segment in a New World primate species

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Evolutionary instability of the major histocompatibility complex class I loci in New World primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Species-specific evolution of MHC class I genes in the higher primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Myelin oligodendrocyte glycoprotein-35-55 peptide induces severe chronic experimental autoimmune encephalomyelitis in HLA-DR2-transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Preclinical assessment of therapeutic antibodies against human CD40 and human interleukin-12/23p40 in a nonhuman primate model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Oligoclonal T cell repertoire in cerebrospinal fluid of patients with inflammatory diseases of the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Accumulation of clonally related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Intrathecal B-cell clonal expansion, an early sign of humoral immunity, in the cerebrospinal fluid of patients with clinically isolated syndrome suggestive of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Transfer of central nervous system autoantigens and presentation in secondary lymphoid organs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

In vivo detection of myelin proteins in cervical lymph nodes of MS patients using ultrasound-guided fine-needle aspiration cytology

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Lymphocyte targeting of the central nervous system: a review of afferent and efferent CNS-immune pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Compartmentalization of the immune response in the central nervous system and natural history of multiple sclerosis. Implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Neurophysiological tests in primary headaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Yin-Yang regulation of autoimmunity by DCs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Self- and nonself-recognition by C-type lectins on dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Autoimmunity: attack, or defence? (The case for a primary lesion theory).

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Surgical excision of CNS-draining lymph nodes reduces relapse severity in chronic-relapsing experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Role of the cervical lymphatics in the Th2-type hierarchy of CNS immune regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Lymphocyte targeting of the brain in adoptive transfer cryolesion-EAE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Late complications of immune deviation therapy in a nonhuman primate

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

Identification of effector-memory CMV-specific T lymphocytes that kill CMV-infected target cells in an HLA-E-restricted fashion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

NKG2D-mediated cytotoxicity toward oligodendrocytes suggests a mechanism for tissue injury in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

T-cell responses to myelin antigens in multiple sclerosis; relevance of the predominant autoimmune reactivity to myelin oligodendrocyte glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819F1D24

10.1097/NEN.0B013E31819F1D24

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference

PubMed ID

19337065